|
Market Closed -
OTC Markets
18:26:06 02/06/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.8200 USD | +2.50% |
|
+54.75% | +64.00% |
| 05-14 | Cell Source, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 | CI |
| 04-07 | Cell Source, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CELL SOURCE, INC. | Bio Therapeutic Drugs | +2.50% | +54.75% | +64.00% | +113.03% | -38.33% | 36.49M |
-
|
-
|
-
|
- Stock Market
- Stocks
- CLCS Stock
- Charts Cell Source, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
